Differentiation of Arginine Vasopressin Antagonistic Effects by Selective V2 versus Dual V2/V1a Receptor Blockade in a Preclinical Heart Failure Model
Mondritzki, Thomas, Kolkhof, Peter, Sabbah, Hani N, Gheorghiade, Mihai, Fürstner, Chantal, Schmeck, Carsten, Siedentop, Harald, Schaefer, Stefan, Truebel, HubertТом:
18
Мова:
english
Журнал:
American Journal of Therapeutics
DOI:
10.1097/mjt.0b013e3181f890ad
Date:
January, 2011
Файл:
PDF, 340 KB
english, 2011
File converter
Більше результатів пошуку
More benefits 
